IRCT201202189067N1CompletedPhase 2
Efficacy of short term prescription of nicorandil on in-hospital outcomes of patients who admitted because of acute coronary syndrome without ST elevation
Vice chancellor for research, Kermanshah University of Medical Siences and Health Services0 sites252 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 252
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criterion:Non ST elevation acute coronary syndrome.
- •Exclusion criteria: myocardial infarction with ST levation and Left Bundle Branch Block
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1IRCT20230110057096N1Rasht University of Medical Sciences264
Recruiting
Phase 2
The effect of nicorandil on arrhythmiaIRCT20181104041555N1Zahedan University of Medical Sciences100
Active, not recruiting
Not Applicable
The effect of intracoronary nicorandil in improving coronary blood flow during primary angioplastyCTRI/2018/10/015937Dr Sreejith A G
Completed
Phase 4
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary InterventionST Elevation Myocardial InfarctionPercutaneous Coronary InterventionNCT04665648Fudan University1,500
Completed
Phase 2
Assessment of the safety of long-term nicotinamide mononucleotide (NMN) in healthy subjects; phase II study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims.JPRN-UMIN000030609Keio University School of Medicine13